Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Sureda

Showing results (251-260 of 381) with videos related to

Pageof 39
Sort By:
Journal of Hematology & Oncology|February 21, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working partyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Leukemia|June 15, 2026
Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party studySimon Renders, Maud Ngoya, Laurence de Leval, et al.
Blood Advances|February 14, 2022
Mass spectrometry vs immunofixation for treatment monitoring in multiple myelomaNoemí Puig, María-Teresa Contreras, Cristina Agulló, et al.
Blood Cancer Discovery|February 6, 2025
Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell LymphomaNora Liebers, Ariane Boumendil, Hervé Finel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2020
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTRGiancarlo Fatobene, Vanderson Rocha, Andrew St Martin, et al.
Hemasphere|May 22, 2025
Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalitionAnna Ossami Saidy, Christophe Peczynski, Catherine Thieblemont, et al.
Transplantation and Cellular Therapy|September 2, 2023
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH StudyMariana Bastos-Oreiro, Antonio Gutierrez, Gloria Iacoboni, et al.
JAMA Oncology|June 5, 2020
Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic TransplantNilanjan Ghosh, Sairah Ahmed, Kwang Woo Ahn, et al.
Hemasphere|August 18, 2025
Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working PartyPhilipp Berning, Maud Ngoya, Won Seog Kim, et al.
Cancers|June 2, 2021
SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line TreatmentMariana Bastos Oreiro, Reyes Martín, Pilar Gomez, et al.
Pageof 39

Showing results (251-260 of 381) with videos related to

Sort By:
Pageof 39
Journal of Hematology & Oncology|February 21, 2026
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working partyEvgenii Shumilov, Maud Ngoya, Philipp Berning, et al.
Leukemia|June 15, 2026
Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party studySimon Renders, Maud Ngoya, Laurence de Leval, et al.
Blood Advances|February 14, 2022
Mass spectrometry vs immunofixation for treatment monitoring in multiple myelomaNoemí Puig, María-Teresa Contreras, Cristina Agulló, et al.
Blood Cancer Discovery|February 6, 2025
Brexucabtagene Autoleucel versus Allogeneic Hematopoietic Cell Transplantation in Relapsed and Refractory Mantle Cell LymphomaNora Liebers, Ariane Boumendil, Hervé Finel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 8, 2020
Nonmyeloablative Alternative Donor Transplantation for Hodgkin and Non-Hodgkin Lymphoma: From the LWP-EBMT, Eurocord, and CIBMTRGiancarlo Fatobene, Vanderson Rocha, Andrew St Martin, et al.
Hemasphere|May 22, 2025
Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalitionAnna Ossami Saidy, Christophe Peczynski, Catherine Thieblemont, et al.
Transplantation and Cellular Therapy|September 2, 2023
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T Cell Therapy Efficacy in Aggressive B Lymphoma: A Real-World GELTAMO/GETH StudyMariana Bastos-Oreiro, Antonio Gutierrez, Gloria Iacoboni, et al.
JAMA Oncology|June 5, 2020
Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic TransplantNilanjan Ghosh, Sairah Ahmed, Kwang Woo Ahn, et al.
Hemasphere|August 18, 2025
Autologous stem cell transplantation in NK/T-cell lymphoma: Prognostic impact of EBV-DNA in a multinational cohort-A study by the EBMT Lymphoma Working PartyPhilipp Berning, Maud Ngoya, Won Seog Kim, et al.
Cancers|June 2, 2021
SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line TreatmentMariana Bastos Oreiro, Reyes Martín, Pilar Gomez, et al.
Pageof 39